In its upcoming report, Idexx Laboratories (IDXX) is predicted by Wall Street analysts to post quarterly earnings of $3.31 per share, reflecting an increase of 35.7% compared to the same period last year. Revenues are forecasted to be $1.07 billion, representing a year-over-year increase of 6.3%. The current level reflects an upward revision of 0.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their i ...